Natco Pharma Limited — Others, 29-03-2025: Trading Window

NATCO Pharma has announced a board meeting to declare the financial results for the quarter and year ending March 31, 2025. In connection with this, the Trading Window will be closed from April 1, 2025, until 48 hours post-announcement. This decision safeguards against insider trading, ensuring compliance with regulations. Investors should note this temporary trading halt, as it may create volatility around the earnings release, potentially offering buying opportunities or risks depending on the results disclosed. Overall, this development emphasizes the company's commitment to governance, which could enhance investor confidence.